Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (AVHHL) Consolidated Net Income (2018 - 2025)

Historic Consolidated Net Income for AVITA Medical (AVHHL) over the last 8 years, with Q4 2025 value amounting to -$11.6 million.

  • AVITA Medical's Consolidated Net Income fell 102.78% to -$11.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$48.6 million, marking a year-over-year increase of 2133.57%. This contributed to the annual value of -$48.6 million for FY2025, which is 2133.57% up from last year.
  • According to the latest figures from Q4 2025, AVITA Medical's Consolidated Net Income is -$11.6 million, which was down 102.78% from -$13.2 million recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Consolidated Net Income ranged from a high of -$4.7 million in Q2 2021 and a low of -$18.7 million during Q1 2024
  • For the 5-year period, AVITA Medical's Consolidated Net Income averaged around -$10.4 million, with its median value being -$9.9 million (2025).
  • As far as peak fluctuations go, AVITA Medical's Consolidated Net Income soared by 6346.6% in 2021, and later crashed by 19958.09% in 2023.
  • Quarter analysis of 5 years shows AVITA Medical's Consolidated Net Income stood at -$5.9 million in 2021, then grew by 7.73% to -$5.5 million in 2022, then plummeted by 199.58% to -$16.4 million in 2023, then soared by 30.17% to -$11.5 million in 2024, then dropped by 1.03% to -$11.6 million in 2025.
  • Its Consolidated Net Income was -$11.6 million in Q4 2025, compared to -$13.2 million in Q3 2025 and -$9.9 million in Q2 2025.